GRAL
GRAIL, Inc.
1W: +8.0%
1M: +3.9%
3M: -44.6%
YTD: -41.2%
1Y: +62.8%
$52.29
+3.64 (+7.48%)
After Hours: $49.95 (-2.34, -4.48%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$7.8M
Congress—
ETF Holdings—
Key Statistics
Market Cap$2.1B
52W Range20.44-118.84
Volume732,585
Avg Volume1,287,308
Beta5.21
Dividend—
Analyst Ratings
Company Info
CEORobert Ragusa
Employees1,000
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2024-06-12
Websitegrail.com
1525 O’Brien Drive
Menlo Park, CA 94025
US
Menlo Park, CA 94025
US
833-694-2553
About GRAIL, Inc.
GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.
Latest News
This Investor Exited a $22 Million GRAIL Stake Before a 50% One-Day Stock Crash Last Month
Here's Why Grail Shares Crushed the Market This Week
Levi & Korsinsky, LLP: Grail (GRAL) Guided to 2030 Cash Runway While Key Trial Risk Went Unaddressed
GRAIL (NASDAQ:GRAL) Shares Up 6.9% Following Analyst Upgrade
Grail upgraded at TD Cowen; says selloff is buying opportunity
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Freidin Aaron | S-Sale | 2,407 | $47.93 | 2026-03-09 |
| Freidin Aaron | S-Sale | 85 | $46.74 | 2026-03-09 |
| Ofman Joshua J. | S-Sale | 2,836 | $47.93 | 2026-03-09 |
| Ofman Joshua J. | S-Sale | 101 | $46.74 | 2026-03-09 |
| RAGUSA ROBERT P | S-Sale | 7,203 | $47.93 | 2026-03-09 |